Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2000
11/15/2000EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/15/2000EP0842227B1 Azothiophenes
11/15/2000CN1273528A Novel heterocyclic analogs of diphenylethylene compounds
11/14/2000US6147219 Process for the preparation of benzothiazolone compounds
11/14/2000US6147101 Treating hyperglycemia
11/14/2000US6147099 Oxazolidinedione derivatives, their production and use
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066613A1 Bone targeting agents for osteoporosis
11/09/2000WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066121A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2372077A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/07/2000US6143765 Enzyme ihibitors of protein
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143742 Treatment for necrotizing infections
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000034273A3 3-(heterocyclyl)-substituted benzoylpyrazols
11/02/2000EP1048659A1 Retinoid receptor agonists
11/02/2000EP1047679A1 Herbicidal n-alkenyl heteroarylyloxyacetamides
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000DE19919218A1 New peptide compounds, e.g. aza-heterocyclic substituted beta-alanine derivatives, are integrin receptor antagonists useful e.g. for treating atherosclerosis, cancer, osteoporosis, hypertension or inflammation
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1058000C Bisaminothiophenol compound, process for synthesizing and use thereof
11/01/2000CN1057999C 4-Aminobenzoylguanidine derivatives
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140427 Vulcanization accelerators suitable for the introduction of polar substituents
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140330 Thiazole derivative
10/31/2000US6140051 Fluorescent dibenzazole derivatives and methods related thereto
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063196A1 New compounds, their preparation and use
10/26/2000WO2000063180A1 Bis-benzazoles and their use as antineoplastic agents
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000021508A3 Novel therapeutic use of compounds with beta-3-agonist activity
10/25/2000EP1045848A1 Process for preparation of 2-aminothiazolecarboxamide derivatives
10/25/2000CN1271346A Method for producing substituted 2-nitroguanidine derivative
10/25/2000CN1271345A Method for producing substituted 2-nitroguanideine derivatives
10/24/2000US6136837 α-substituted benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000DE19926233C1 Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine
10/19/2000CA2370425A1 Pharmaceutical compounds
10/18/2000EP1044194A1 Receptor with an affinity for compounds of the oxazoline class
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP1043996A2 Treatment of dyskinesias
10/18/2000CN1270589A Epothilone derivatives
10/17/2000US6133295 Pharmaceutical composition
10/17/2000US6133293 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action; potent depressive effect on diabetic hyperglycemia; 2,4-thiazolidinediones and oxazolidinediones
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000CA2086179C Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses
10/12/2000WO2000060027A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
10/12/2000CA2268590A1 Ion channel modulating compounds and uses thereof
10/11/2000EP1043319A1 Novel alkylamino derivatives
10/11/2000EP1042327A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042306A1 Thiazole-, isothiazole- and thiadiazole-derivatives having microbicidal and plant immunizing activities
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042292A1 Method for producing isoureas
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000EP0703971B1 Use of n,n-diacetic alpha-alanine and its salts as biodegradable complexing agents for alkaline earth and heavy metal ions in cleaning compositions for dishwashing
10/11/2000CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists
10/10/2000US6130251 Use as agents for combating pests.
10/10/2000US6130217 Antitumor
10/10/2000CA2016665C Rhodanine derivatives and pharmaceutical compositions
10/05/2000WO2000058405A2 Squaraine dyes
10/05/2000WO2000058293A2 Glucokinase activators
10/05/2000WO2000058254A1 Synthesis of epothilones
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2366263A1 Squaraine dyes
10/04/2000EP1041075A1 Procedure for the preparation of dioxopenicillanic acid derivatives
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 337